All data are based on the daily closing price as of November 20, 2025
a
Alfresa Holdings
2784.TSE
14.47 USD
-0.13
-0.89%
Overview
Last close
14.47 usd
Market cap
2.63B usd
52 week high
16.89 usd
52 week low
13.01 usd
Target price
14.63 usd
Valuation
P/E
17.0377
Forward P/E
N/A
Price/Sales
0.137
Price/Book Value
0.8512
Enterprise Value
1.65B usd
EV/Revenue
0.0856
EV/EBITDA
5.0347
Key financials
Revenue TTM
19.30B usd
Gross Profit TTM
1.38B usd
EBITDA TTM
343.72M usd
Earnings per Share
0.86 usd
Dividend
0.42 usd
Total assets
10.15B usd
Net debt
N/A usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.